Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord
- PMID: 2492344
Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord
Abstract
In the present study the neuronal source of adenosine released by K+, morphine and norepinephrine (NE) from the spinal cord was investigated. Intrathecal pretreatment with 5,7-dihydroxytryptamine and 6-hydroxydopamine reduced spinal 5-hydroxytryptamine and NE levels, respectively, but had no effect on adenosine release from dorsal spinal cord synaptosomes evoked by K+ or morphine. NE-evoked release of adenosine was unaffected by 5,7-dihydroxytryptamine but increased by 6-hydroxydopamine. Subcutaneous pretreatment of neonatal or intrathecal pretreatment of adult rats with capsaicin increased nociceptive thresholds and reduced the release of adenosine evoked by K+ and morphine but not NE from dorsal spinal cord synaptosomes. Intrathecal capsaicin also inhibited morphine-evoked release of adenosine in vivo. K+ and morphine released only small amounts of adenosine from ventral spinal cord synaptosomes whereas NE released significant amounts. Exposure of dorsal, but not ventral, spinal cord synaptosomes to capsaicin produced a dose- and Ca++-dependent release of adenosine, which was reduced by capsaicin pretreatment (neonatal and adult) and inhibition of ecto-5'-nucleotidase. Capsaicin also released endogenous ATP from dorsal spinal cord synaptosomes. These results suggest that primary afferent nerve terminals in the dorsal horn of the spinal cord release adenosine in response to morphine and K+, and a nucleotide (possibly ATP) in response to capsaicin. Adenosine does not appear to be released from the terminals of descending aminergic pathways. The source of purines released by NE is less certain.
Similar articles
-
Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.J Pharmacol Exp Ther. 1991 Jul 1;258(1):370-80. J Pharmacol Exp Ther. 1991. PMID: 1906540
-
Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.J Pharmacol Exp Ther. 1987 Nov;243(2):657-65. J Pharmacol Exp Ther. 1987. PMID: 2824755
-
ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin.Brain Res. 1993 Apr 30;610(1):32-8. doi: 10.1016/0006-8993(93)91213-c. Brain Res. 1993. PMID: 8518929
-
Adenosine release may mediate spinal analgesia by morphine.Trends Pharmacol Sci. 1989 May;10(5):186-9. doi: 10.1016/0165-6147(89)90235-6. Trends Pharmacol Sci. 1989. PMID: 2667227 Review.
-
Adenosine in the spinal cord and periphery: release and regulation of pain.Prog Neurobiol. 2003 Apr;69(5):313-40. doi: 10.1016/s0301-0082(03)00050-9. Prog Neurobiol. 2003. PMID: 12787573 Review.
Cited by
-
Direct interaction of adenosine with the TRPV1 channel protein.J Neurosci. 2004 Apr 7;24(14):3663-71. doi: 10.1523/JNEUROSCI.4773-03.2004. J Neurosci. 2004. PMID: 15071115 Free PMC article.
-
Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice.Br J Pharmacol. 2003 Jul;139(6):1187-95. doi: 10.1038/sj.bjp.0705340. Br J Pharmacol. 2003. PMID: 12871838 Free PMC article.
-
PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine.Mol Pain. 2011 Oct 19;7:80. doi: 10.1186/1744-8069-7-80. Mol Pain. 2011. PMID: 22011440 Free PMC article.
-
Purinergic signalling: ATP release.Neurochem Res. 2001 Sep;26(8-9):959-69. doi: 10.1023/a:1012388618693. Neurochem Res. 2001. PMID: 11699948 Review.
-
The role of spinal inhibitory neuroreceptors in the antihyperalgesic effect of warm water immersion therapy.Braz J Phys Ther. 2021 Jan-Feb;25(1):56-61. doi: 10.1016/j.bjpt.2020.02.001. Epub 2020 Feb 12. Braz J Phys Ther. 2021. PMID: 32070652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials